Titering replication-defective rSV40 vectors
- PMID: 20516175
- DOI: 10.1101/pdb.prot5437
Titering replication-defective rSV40 vectors
Abstract
Recombinant simian virus 40 (rSV40)-derived vectors are particularly useful for gene delivery to bone marrow progenitor cells and their differentiated derivatives, certain types of epithelial cells (e.g., hepatocytes), and central nervous system neurons and microglia. They integrate rapidly into cellular DNA to provide long-term gene expression in vitro and in vivo in both resting and dividing cells. Techniques used to produce, purify, and quantitate these vectors are simple, give reproducible results, and may be used to generate vectors that are deleted only for large T antigen (Tag), or for all SV40-coding sequences capable of carrying up to 5 kb of foreign DNA. Viruses are purified by centrifugation using discontinuous sucrose or cesium chloride (CsCl) gradients. Resulting vectors are replication-incompetent and contain no detectable wild-type SV40 revertants. Viruses are titered by quantitative polymerase chain reaction (qPCR), described here. qPCR measures the number of rSV40 genomes in purified viral stocks using primers specific for the rSV40, coupled with SYBR Green detection of PCR products. Sample purity is assessed using qPCR via melt (dissociation) curve analysis. The only specialized equipment necessary is a quantitative real-time PCR machine.
Similar articles
-
Production of SV40-derived vectors.Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5436. doi: 10.1101/pdb.prot5436. Cold Spring Harb Protoc. 2010. PMID: 20516174
-
Factors influencing the production of recombinant SV40 vectors.Mol Ther. 2004 Oct;10(4):780-91. doi: 10.1016/j.ymthe.2004.06.1014. Mol Ther. 2004. PMID: 15451462
-
Gene therapy using SV40-derived vectors: what does the future hold?J Cell Physiol. 1999 Dec;181(3):375-84. doi: 10.1002/(SICI)1097-4652(199912)181:3<375::AID-JCP1>3.0.CO;2-8. J Cell Physiol. 1999. PMID: 10528223 Review.
-
Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.Gene Ther. 2000 May;7(10):886-95. doi: 10.1038/sj.gt.3301159. Gene Ther. 2000. PMID: 10845727
-
SV40-based gene therapy vectors: turning an adversary into a friend.Curr Opin Mol Ther. 2000 Oct;2(5):570-8. Curr Opin Mol Ther. 2000. PMID: 11249759 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources